retatrutide efectos secundarios Estamos viendo el futuro del tratamiento de la obesidad? 👀 Retatrutide, un agonista triple de GLP-1, GIP y glucagón, acaba de presentar resultados que están llamando la atención de toda la endocrinología 🚨💉 | Un nuevo medicamento

Saxenda (liraglutide) is a temperature-sensitive GLP-1 receptor agonist used for weight management in adults with obesity or overweight with weight-related comorbidities

Diabetes Metab Res Rev 31(6):610618 Bronden A, Alber A, Rohde U, Gasbjerg LS, Rehfeld JF, Holst JJ et al (2018) The bile acid-sequestering resin sevelamer eliminates the acute GLP-1 stimulatory effect of endogenously released bile acids in patients with type 2 diabetes

Another rapidly progressive manifestation of thiamin deficiency reported within the first six weeks after surgery is polyradiculoneuropathy, which resembles a longer-term disorder Guillain-Barr syndrome (GBS)

The payer defines a window of five, six, or twelve months and a renewal test scored in percentage points of baseline weight

Hathaway, J

You could see visible improvements in skin and hair appearance within 6-8 weeks of daily use